Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple–negative breast cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple–negative breast cancer cells ; volume:22 ; number:1 ; day:16 ; month:9 ; year:2023 ; pages:1-14 ; date:12.2023
Lipids in health and disease ; 22, Heft 1 (16.9.2023), 1-14, 12.2023
- Creator
-
Wu, Jinna
Li, Jia
Xu, Huiya
Qiu, Ni
Huang, Xiaojia
Li, Hongsheng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-023-01912-1
- URN
-
urn:nbn:de:101:1-2024020515162935199294
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wu, Jinna
- Li, Jia
- Xu, Huiya
- Qiu, Ni
- Huang, Xiaojia
- Li, Hongsheng
- SpringerLink (Online service)
Other Objects (12)
Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
Periostin
Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
Prognostic model based on tumor stemness genes for triple-negative breast cancer
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA
Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
Periostin
Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
Prognostic model based on tumor stemness genes for triple-negative breast cancer
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA
Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
Periostin
Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
Prognostic model based on tumor stemness genes for triple-negative breast cancer
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells